Utilisation and outcomes of a mobile (ambulance and air transport) venovenous extracorporeal membrane oxygenation (VV-ECMO) program in Poland during the COVID-19 pandemic - a retrospective, two-centres, case-series study

被引:0
|
作者
Rypulak, Elzbieta [1 ]
Szczukocka, Marta [1 ]
Czarnik, Tomasz [2 ]
机构
[1] Med Univ Lublin, Dept Anaesthesiol & Intens Care 2, 16 Staszica St, PL-20081 Lublin, Poland
[2] Univ Opole, Inst Med Sci, Dept Anaesthesiol, Intens Care & Reg ECMO Ctr, Opole, Poland
关键词
COVID-19; VV-ECMO; transport; ARDS; complications; mortality; CORONAVIRUS DISEASE 2019; IMPLEMENTATION; MORTALITY;
D O I
10.5114/ait.2024.139526
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Many patients required mechanical ventilation support due to severe COVID-19 pneumonia. A significant proportion of mechanically ventilated patients also required venovenous extracorporeal membrane oxygenation (VV-ECMO) due to refractory hypoxemia. A high demand for VV-ECMO support during the pandemic was challenging due to many factors, including limited resources and lack of established transfer protocols. This study aims to present the organisation and outcomes of a mobile VV-ECMO program in two high-volume centres in Poland during the COVID-19 pandemic. Methods: This retrospective, two-centre case series study, which lasted 36 months, was conducted between March 10, 2020, and January 31, 2023. The data of all patients transferred using venovenous extracorporeal membrane oxygenation (VV-ECMO) were analysed, including five women in the perinatal period with severe respiratory failure attributed to the COVID-19 virus. The analysis encompassed baseline patient demographics, ECMO therapy, duration of mechanical ventilation, and patient survival to ICU discharge. Results: We assessed 86 patients who met the ELSO inclusion criteria and were transported during VV-ECMO support. Mortality in the analysed group was high (80.3%). Despite high mortality, VV-ECMO appeared to be a safe procedure in COVID-19 patients with severe ARDS. No complications were noted in more than half of the analysed procedures. Despite the above, many severe complications were observed, including stroke or cerebral haemorrhage (9.8%) and limb or gut ischemia (1.6%). The most common problems co-existing with VV-ECMO treatment were bleeding complications (34.4%). Conclusions: The ICU mortality rate among patients requiring VV-ECMO for COVID-19 in high-volume ECMO centres was high but not associated with the type of transportation.
引用
收藏
页码:141 / 145
页数:5
相关论文
共 4 条
  • [1] Outcomes by cannulation methods for venovenous extracorporeal membrane oxygenation during COVID-19: A multicenter retrospective study
    Saeed, Omar
    Stein, Louis H.
    Cavarocchi, Nicolas
    Tatooles, Antone J.
    Mustafa, Asif
    Jorde, Ulrich P.
    Alvarez, Chikezie
    Gluck, Jason
    Saunders, Paul
    Abrol, Sunil
    De Anda, Abe
    Goldstein, Daniel J.
    Silvestry, Scott
    ARTIFICIAL ORGANS, 2022, 46 (08) : 1659 - 1668
  • [2] Tracheostomy in COVID-19 ARDS Patients on Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) Support: A Single Center Retrospective Study
    Bhandari, B. S.
    Salamo, O.
    Dinh, K.
    Patel, J.
    Patel, M.
    De Armas, I. Salas
    Akay, M.
    Jani, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [3] Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES): an international, multicentre, retrospective cohort study
    Schmidt, Matthieu
    Hajage, David
    Landoll, Micha
    Pequignot, Benjamin
    Langouet, Elise
    Amalric, Matthieu
    Mekontso-Dessap, Armand
    Chiscano-Camon, Luis
    Surman, Katy
    Finnerty, Dylan
    Santa-Teresa, Patricia
    Arcadipane, Antonio
    Millan, Pablo
    Roncon-Albuquerque, Roberto, Jr.
    Blandino-Ortiz, Aaron
    Blanco-Schweizer, Pablo
    Ricart, Pilar
    Gimeno-Costa, Ricardo
    Albacete, Carlos Luis
    Fortuna, Philip
    Schellongowski, Peter
    Dauwe, Dieter
    Winiszewski, Hadrien
    Kimmoun, Antoine
    Levy, Bruno
    Hermans, Greet
    Grasselli, Giacomo
    Lebreton, Guillaume
    Guervilly, Christophe
    Martucci, Gennaro
    Karagiannidis, Christian
    Riera, Jordi
    Combes, Alain
    LANCET RESPIRATORY MEDICINE, 2023, 11 (02): : 163 - 175
  • [4] Comparative outcomes of extracorporeal membrane oxygenation for COVID- 19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES): an international, multicentre, retrospective cohort study (vol 11, pg 163, 2023)
    Beasley, R.
    Chang, A. B.
    LANCET RESPIRATORY MEDICINE, 2023, 11 (03): : E25 - E25